Inhibition of TXNRD2 can induce cancer cell senescence and inhibit tumor growth; elevated serum TXNRD2 indicates castration‐resistant transformation and may be used for early prediction of drug resistance (Wang et al. 2025; Yang et al. 2020). This evidence concerns the gene TXNRD2 and cancer.